Compare Bank of Montreal (BMO) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs Twist Bioscience Corp — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while Twist Bioscience Corp trades at $92.62 (market cap $5.63B). The key difference: Bank of Montreal is far larger — about 22.2× Twist Bioscience Corp's market cap, and Bank of Montreal pays a 2.77% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| BMO | TWST | |
|---|---|---|
Market Cap | $124.81B | $5.63B |
Sector | Financials | Health |
52-Week High | $180.86 | $102.88 |
52-Week Low | $110.44 | $24.16 |
Dividend Yield | 2.77% | — |
Enterprise Value | — | $5.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
